TAK
Takeda Pharmaceutical·NYSE
--
--(--)
--
--(--)
7.20 / 10
Outperform
With a technical rating of 7.2/10, the security shows favorable technical configuration. Momentum advantages in RSI Overbought, MACD Death Cross, and Marubozu White are challenged by vulnerabilities in no significant factors. Technical prognosis: cautiously optimistic.
Analysis Checks(3/3)
RSI Overbought
Score6.58/10
Win Rate60.00%
Hist. Signals20
Avg Return0.82%
Score6.58/10
Win Rate60.00%
Hist. Signals20
Avg Return0.82%
Marubozu White
Score7.27/10
Win Rate63.16%
Hist. Signals38
Avg Return0.59%
Score7.27/10
Win Rate63.16%
Hist. Signals38
Avg Return0.59%
MACD Death Cross
Score7.75/10
Win Rate75.00%
Hist. Signals8
Avg Return0.96%
Score7.75/10
Win Rate75.00%
Hist. Signals8
Avg Return0.96%
RSI Overbought
Score6.58/10
Win Rate60.00%
Hist. Signals20
Avg Return0.82%
Score6.58/10
Win Rate60.00%
Hist. Signals20
Avg Return0.82%
MACD Death Cross
Score7.75/10
Win Rate75.00%
Hist. Signals8
Avg Return0.96%
Score7.75/10
Win Rate75.00%
Hist. Signals8
Avg Return0.96%
Marubozu White
Score7.27/10
Win Rate63.16%
Hist. Signals38
Avg Return0.59%
Score7.27/10
Win Rate63.16%
Hist. Signals38
Avg Return0.59%
Technical Analysis of TAK?
- TAK presents a Outperform setup with a Technical Score of 7.20/10. Key technical indicators highlight an RSI of 58.60 and a MACD of 0.01, with the trend anchored by the 50-Day SMA at 17.87. Traders should monitor key support at 18.16 and resistance at 18.36.
